AllianceBernstein’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $210K | Buy |
187,700
+41,120
| +28% | +$46.1K | ﹤0.01% | 3040 |
|
|
2025
Q1 | $116K | Hold |
146,580
| – | – | ﹤0.01% | 3045 |
|
|
2024
Q4 | $242K | Hold |
146,580
| – | – | ﹤0.01% | 2975 |
|
|
2024
Q3 | $513K | Hold |
146,580
| – | – | ﹤0.01% | 2651 |
|
|
2024
Q2 | $481K | Buy |
146,580
+46,200
| +46% | +$152K | ﹤0.01% | 2693 |
|
|
2024
Q1 | $737K | Sell |
100,380
-60,380
| -38% | -$443K | ﹤0.01% | 2417 |
|
|
2023
Q4 | $601K | Sell |
160,760
-800
| -0.5% | -$2.99K | ﹤0.01% | 2519 |
|
|
2023
Q3 | $343K | Buy |
161,560
+34,430
| +27% | +$73K | ﹤0.01% | 2744 |
|
|
2023
Q2 | $605K | Buy |
127,130
+25,330
| +25% | +$121K | ﹤0.01% | 2538 |
|
|
2023
Q1 | $580K | Sell |
101,800
-200,000
| -66% | -$1.14M | ﹤0.01% | 2492 |
|
|
2022
Q4 | $3.05M | Buy |
301,800
+200,000
| +196% | +$2.02M | ﹤0.01% | 1664 |
|
|
2022
Q3 | $2.28M | Sell |
101,800
-39,990
| -28% | -$896K | ﹤0.01% | 1801 |
|
|
2022
Q2 | $3.51M | Sell |
141,790
-157
| -0.1% | -$3.89K | ﹤0.01% | 1618 |
|
|
2022
Q1 | $5.5M | Buy |
141,947
+357
| +0.3% | +$13.8K | ﹤0.01% | 1532 |
|
|
2021
Q4 | $8.28M | Hold |
141,590
| – | – | ﹤0.01% | 1343 |
|
|
2021
Q3 | $8.39M | Sell |
141,590
-600
| -0.4% | -$35.6K | ﹤0.01% | 1324 |
|
|
2021
Q2 | $12.3M | Buy |
142,190
+13,020
| +10% | +$1.13M | 0.01% | 1121 |
|
|
2021
Q1 | $10.7M | Buy |
129,170
+29,970
| +30% | +$2.47M | ﹤0.01% | 1161 |
|
|
2020
Q4 | $9.02M | Buy |
99,200
+7,800
| +9% | +$709K | ﹤0.01% | 1174 |
|
|
2020
Q3 | $3.65M | Buy |
91,400
+5,600
| +7% | +$224K | ﹤0.01% | 1502 |
|
|
2020
Q2 | $2.94M | Buy |
85,800
+5,100
| +6% | +$175K | ﹤0.01% | 1616 |
|
|
2020
Q1 | $1.79M | Buy |
80,700
+9,400
| +13% | +$209K | ﹤0.01% | 1718 |
|
|
2019
Q4 | $1.4M | Buy |
71,300
+2,800
| +4% | +$54.8K | ﹤0.01% | 2123 |
|
|
2019
Q3 | $1.06M | Hold |
68,500
| – | – | ﹤0.01% | 2214 |
|
|
2019
Q2 | $1.39M | Buy |
68,500
+8,700
| +15% | +$177K | ﹤0.01% | 2161 |
|
|
2019
Q1 | $1.05M | Buy |
59,800
+2,100
| +4% | +$36.9K | ﹤0.01% | 2221 |
|
|
2018
Q4 | $740K | Buy |
57,700
+15,100
| +35% | +$194K | ﹤0.01% | 2325 |
|
|
2018
Q3 | $694K | Buy |
42,600
+15,000
| +54% | +$244K | ﹤0.01% | 2476 |
|
|
2018
Q2 | $313K | Buy |
27,600
+16,600
| +151% | +$188K | ﹤0.01% | 2788 |
|
|
2018
Q1 | $107K | Buy |
+11,000
| New | +$107K | ﹤0.01% | 2945 |
|